{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T10:27:52Z","timestamp":1776680872312,"version":"3.51.2"},"update-to":[{"DOI":"10.1002\/14651858.cd011541","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000}}],"reference-count":66,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011541.pub2","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T13:06:41Z","timestamp":1554728801000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis"],"prefix":"10.1002","volume":"2019","author":[{"given":"Annabel","family":"Maruani","sequence":"first","affiliation":[{"name":"Universit\u00e9 Fran\u00e7ois-Rabelais de Tours; Department of Dermatology; Tours France 37044"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahtab","family":"Samimi","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Fran\u00e7ois-Rabelais de Tours; Department of Dermatology; Tours France 37044"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Stembridge","sequence":"additional","affiliation":[{"name":"Addenbrooke's Hospital; Department of Dermatology; Hills Road Cambridge UK CB2 0QQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania","family":"Abdel Hay","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Cairo University; Department of Dermatology; 13th Abrag Othman Kournish el Maadi Cairo Egypt 11431"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Tavernier","sequence":"additional","affiliation":[{"name":"INSERM 0202, Universit\u00e9 Fran\u00e7ois-Rabelais de Tours; Centre d'Investigation Clinique de Tours; 2 boulevard Tonnell\u00e9 Tours France (Cedex 9) 37044"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Hughes","sequence":"additional","affiliation":[{"name":"The University of Nottingham; c\/o Cochrane Skin Group; A103, King's Meadow Campus Lenton Lane Nottingham UK NG7 2NR"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Le Cleach","sequence":"additional","affiliation":[{"name":"H\u00f4pital Henri Mondor; Department of Dermatology; 51 avenue du G\u00e9n\u00e9ral de Lattre de Tassigny Cr\u00e9teil France 94010"},{"name":"Universit\u00e9 Paris Est Cr\u00e9teil (UPEC); Epidemiology in dermatology and evaluation of therapeutics (EpiDermE) - EA 7379; Cr\u00e9teil France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD011541.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/BF00184491","article-title":"A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile","volume":"71","author":"Grimminger","year":"1993","journal-title":"Clinical Investigator"},{"issue":"8582","key":"10.1002\/14651858.CD011541.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(88)91181-6","article-title":"A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis","volume":"1","author":"Bittiner","year":"1988","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD011541.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-4632.2004.02398.x","article-title":"The effect of maintenance narrow-band ultraviolet B therapy on the duration of remission for psoriasis: a prospective randomized clinical trial","volume":"45","author":"Boztepe","year":"2006","journal-title":"International Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD011541.pub2-BIB0004|cit4","first-page":"707","article-title":"Management of guttate and generalized psoriasis vulgaris: prospective randomized study","volume":"43","author":"Caca-Biljanovska","year":"2002","journal-title":"Croatian Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD011541.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1346-8138.2005.tb00775.x","article-title":"Narrow-band ultraviolet B phototherapy in patients with psoriasis: for which types of psoriasis is it more effective?","volume":"32","author":"Gokdemir","year":"2005","journal-title":"Journal of Dermatology"},{"key":"10.1002\/14651858.CD011541.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/09546639609086861","article-title":"8-MOP bath PUVA in the treatment of psoriasis: clinical results in 42 patients","volume":"7","author":"Gomez","year":"1996","journal-title":"Journal of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD011541.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.1992.tb14815.x","article-title":"A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs. etretinate (re-TL-01) vs. etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients","volume":"127","author":"Green","year":"1992","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD011541.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2133.1989.tb01378.x","article-title":"Double-blind, placebo-controlled study to evaluate the efficacy of fish oil and low-dose UVB in the treatment of psoriasis","volume":"120","author":"Gupta","year":"1989","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD011541.pub2-BIB0009|cit9","first-page":"315","article-title":"Oral 8-methoxypsoralen-UVA (PUVA) therapy in psoriasis: comparison of 3 treatment protocols","volume":"31","author":"Hofmann","year":"1980","journal-title":"Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und Verwandte Gebiete"},{"issue":"2","key":"10.1002\/14651858.CD011541.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D33R84W3TX","article-title":"Treatment of psoriasis with light and heat energy (LHE): a preliminary study","volume":"10","author":"Leviav","year":"2004","journal-title":"Dermatology Online Journal"},{"issue":"6","key":"10.1002\/14651858.CD011541.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/1523-1747.ep12496022","article-title":"Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial","volume":"68","author":"Melski","year":"1977","journal-title":"Journal of Investigative Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD011541.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-008-0883-9","article-title":"Antigens from Leishmania amastigotes induced clinical remission of psoriasis","volume":"301","author":"O'Daly","year":"2009","journal-title":"Archives of Dermatological Research"},{"issue":"2","key":"10.1002\/14651858.CD011541.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000079596","article-title":"Rapid clearance of psoriatic skin lesions induced by topical cyclopamine. A preliminary proof of concept study","volume":"209","author":"Tas","year":"2004","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"4","key":"10.1002\/14651858.CD011541.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1523-1747.2003.12094.x","article-title":"Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis","volume":"120","author":"Asumalahti","year":"2003","journal-title":"Journal of Investigative Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD011541.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T cells in the pathogenesis of psoriasis","volume":"9","author":"Cai","year":"2012","journal-title":"Cellular & Molecular Immunology"},{"issue":"6","key":"10.1002\/14651858.CD011541.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2133.2001.04505.x","article-title":"A systematic review of treatments for guttate psoriasis","volume":"145","author":"Chalmers","year":"2001","journal-title":"British Journal of Dermatology"},{"issue":"9271","key":"10.1002\/14651858.CD011541.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(00)04954-0","article-title":"Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial","volume":"357","author":"Chaudhari","year":"2001","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD011541.pub2-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009481","article-title":"Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis","author":"Chen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011541.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0190-9622(92)70012-5","article-title":"Cyclosporine in psoriasis: a multicenter dose-finding study in severe plaque psoriasis. The German Multicenter Study","volume":"26","author":"Christophers","year":"1992","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD011541.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semarthrit.2010.04.003","article-title":"Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis","volume":"40","author":"Collamer","year":"2010","journal-title":"Seminars in Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD011541.pub2-BIB0021|cit21","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD011541.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0190-9622(92)70299-U","article-title":"Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right\/left comparative, vehicle-controlled study","volume":"27","author":"Dubertret","year":"1992","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD011541.pub2-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011571.pub2","article-title":"Antistreptococcal interventions for guttate and chronic plaque psoriasis","author":"Dupire","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7109","key":"10.1002\/14651858.CD011541.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD011541.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0190-9622(88)70086-9","article-title":"Acitretin improves psoriasis in a dose-dependent fashion","volume":"18","author":"Goldfarb","year":"1988","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD011541.pub2-BIB0026|cit26","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD011541.pub2-BIB0027|cit27","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011541.pub2-BIB0028|cit28","unstructured":"Higgins JP Deeks JJ Altman DG Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD011541.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0190-9622(95)90186-8","article-title":"Calcipotriene ointment 0.005% for psoriasis: a safety and efficacy study. Calcipotriene Study Group","volume":"32","author":"Highton","year":"1995","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD011541.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1006\/clin.1996.0140","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"80","author":"Ho","year":"1996","journal-title":"Clinical Immunology & Immunopathology"},{"issue":"4","key":"10.1002\/14651858.CD011541.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1067\/mjd.2001.112400","article-title":"Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study","volume":"44","author":"Ho","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD011541.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2273.1996.tb01108.x","article-title":"Clearance of recalcitrant psoriasis after tonsillectomy","volume":"21","author":"Hone","year":"1996","journal-title":"Clinical Otolaryngology and Allied Sciences"},{"issue":"10","key":"10.1002\/14651858.CD011541.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1346-8138.2010.00871.x","article-title":"Clinical course of guttate psoriasis: long-term follow-up study","volume":"37","author":"Ko","year":"2010","journal-title":"Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD011541.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1365-2133.1998.02319.x","article-title":"A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group","volume":"139","author":"Koo","year":"1998","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD011541.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1067\/mjd.2002.127247","article-title":"A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis","volume":"47","author":"Krueger","year":"2002","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD011541.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1346-8138.2011.01452.x","article-title":"Epidemiology and clinical features of pediatric psoriasis in tertiary referral psoriasis clinic","volume":"39","author":"Kwon","year":"2012","journal-title":"Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD011541.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archderm.139.6.719","article-title":"An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis","volume":"139","author":"Lebwohl","year":"2003","journal-title":"Archives of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD011541.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2133.2009.09491.x","article-title":"Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial","volume":"162","author":"Lebwohl","year":"2010","journal-title":"British Journal of Dermatology"},{"issue":"21","key":"10.1002\/14651858.CD011541.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","article-title":"Etanercept as monotherapy in patients with psoriasis","volume":"349","author":"Leonardi","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011541.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/1523-1747.ep12468941","article-title":"A potential role for superantigens in the pathogenesis of psoriasis","volume":"100","author":"Leung","year":"1993","journal-title":"Journal of Investigative Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD011541.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.0022-202X.2004.23611.x","article-title":"Psoriasis phenotype at disease onset: clinical characterization of 400 adult cases","volume":"124","author":"Mallbris","year":"2005","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1002\/14651858.CD011541.pub2-BIB0042|cit42","doi-asserted-by":"crossref","unstructured":"Martin BA Chalmers RJ Telfer NR How great is the risk of further psoriasis following a single episode of acute guttate psoriasis? Archives of Dermatology 1996 717 8","DOI":"10.1001\/archderm.1996.03890300147032"},{"issue":"1","key":"10.1002\/14651858.CD011541.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2007.09.010","article-title":"Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial","volume":"58","author":"Menter","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD011541.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaad.2009.08.026","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy","volume":"62","author":"Menter","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD011541.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","article-title":"Definition of treatment goals for moderate to severe psoriasis: a European consensus","volume":"303","author":"Mrowietz","year":"2011","journal-title":"Archives of Dermatological Research"},{"issue":"3","key":"10.1002\/14651858.CD011541.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/mjd.2001.110876","article-title":"Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study","volume":"44","author":"Naldi","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD011541.pub2-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001976","article-title":"Antistreptococcal interventions for guttate and chronic plaque psoriasis","author":"Owen","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD011541.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1046\/j.1365-4362.1998.00512.x","article-title":"Autoantibodies to autologous skin in guttate and plaque forms of psoriasis and cross-reaction of skin antigens with streptococcal antigens","volume":"37","author":"Perez-Lorenzo","year":"1998","journal-title":"International Journal of Dermatology"},{"issue":"85","key":"10.1002\/14651858.CD011541.pub2-BIB0049|cit49","first-page":"133","article-title":"Oral retinoid for psoriasis. A report of a double blind study","volume":"59","author":"Pettit","year":"1979","journal-title":"Acta Dermato-Venereologica. Supplementum"},{"issue":"2","key":"10.1002\/14651858.CD011541.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaad.2014.10.013","article-title":"Effect of tonsillectomy on psoriasis: a systematic review","volume":"72","author":"Rachakonda","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD011541.pub2-BIB0051|cit51","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"5","key":"10.1002\/14651858.CD011541.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/bjd.12276","article-title":"Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses","volume":"168","author":"Samarasekera","year":"2013","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD011541.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2133.2007.08315.x","article-title":"Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)","volume":"158","author":"Saurat","year":"2008","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD011541.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bjd.14337","article-title":"Report from the kick-off meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN)","volume":"174","author":"Schmitt","year":"2016","journal-title":"British Journal of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD011541.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jclinepi.2010.02.005","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"63","author":"Schulz","year":"2010","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011541.pub2-BIB0056|cit56","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD011541.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/jid.2009.391","article-title":"How good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic review","volume":"130","author":"Spuls","year":"2010","journal-title":"Journal of Investigative Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD011541.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archderm.1992.01680110049004","article-title":"The role of streptococcal infection in the initiation of guttate psoriasis","volume":"128","author":"Telfer","year":"1992","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD011541.pub2-BIB0059|cit59","unstructured":"Ankit Rohatgi WebPlotDigitizer January 2018"},{"issue":"1","key":"10.1002\/14651858.CD011541.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0190-9622(97)70216-0","article-title":"Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect","volume":"37","author":"Weinstein","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD011541.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1067\/mjd.2003.103","article-title":"Tazarotene cream in the treatment of psoriasis: two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks","volume":"48","author":"Weinstein","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD011541.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2133.1976.tb00820.x","article-title":"HL-A antigens in patients with guttate psoriasis","volume":"95","author":"Williams","year":"1976","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD011541.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2133.2010.09742.x","article-title":"Foxp3+ regulatory T cells and related cytokines differentially expressed in plaque vs. guttate psoriasis vulgaris","volume":"163","author":"Yan","year":"2010","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD011541.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1346-8138.2005.tb00723.x","article-title":"Acute guttate psoriasis patients have positive streptococcus hemolyticus throat cultures and elevated antistreptococcal M6 protein titers","volume":"32","author":"Zhao","year":"2005","journal-title":"Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD011541.pub2-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001213","article-title":"Interventions for guttate psoriasis","author":"Chalmers","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011541.pub2-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011541","article-title":"Interventions for guttate psoriasis","author":"Maruani","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011541.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T14:32:25Z","timestamp":1671805945000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011541.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":66,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011541.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]}}}